Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Beth Israel Deaconess Medical Center
Patient adherence with topical mesalamine is low. Behavioral and psycho-social barriers to topical mesalamine adherence exist in patients with UC. These factors can be identified using qualitative testing in order to develop and design appropriate behavioral interventions to reduce non-adherence.
The investigators will undertake an observational study of medication persistence in 100 patients in the BIDMC clinic, "Persistence Cohort". Persistence will be measured using 12-month pharmacy refill data. The investigators will also employ a qualitative research design with discrete choice modeling in two phases: Phase I - Initial Interviews with 10 patients and Phase II - Focus Groups (2) with 5 patients each.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
must have ulcerative colitis diagnosed by a doctor at least 1 month prior to study participation
must be prescribed topical mesalamine (e.g. Rowasa enemas or Canasa suppositories) by a doctor
must be receiving care at Beth Israel Deaconess Medical Center
You may not be if
no diagnosis of ulcerative colitis
no prescription for topical mesalamine
not receiving care at Beth Israel Deaconess Medical Center
Clareo Health | Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
